Skip to content
BidBenchmark
Special NoticeAmendment 2

6550--INTENT TO SOLE SOURCE - Buffalo VA Thermo Fisher GENEXUS Reagents

242-NETWORK CONTRACT OFFICE 02 (36C242)

Response status

Historical record

Aug 27, 2026, 2:00 PM UTC

This notice is no longer open.

Posted
Aug 20, 2026
Archive date
Sep 6, 2026
SAM status
Active
This is a preserved solicitation record. The response window is closed because the published deadline passed.

Answer-first brief

What the source record says

  • 242-NETWORK CONTRACT OFFICE 02 (36C242) published this special notice.
  • The notice uses NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing).

Procurement identity

Notice ID
e2ab630611094426911b176eef82f87b
Solicitation
36C24226Q0938
Base type
Special Notice
Version
2 of 2

Solicitation facts

Structured fields from the current SAM notice version. A dash means the source did not publish a value.

Notice type
Special Notice
Solicitation number
36C24226Q0938
Set-aside
Set-aside code
Posted
Aug 20, 2026
Responses due
Aug 27, 2026, 2:00 PM UTC
Archive date
Sep 6, 2026
Archive type
autocustom
Base type
Special Notice
Organization type
OFFICE
Benchmark category
Category confidence
Category source
Last seen
Aug 29, 2026

Buyer and place

Office hierarchy and place of performance as published.

Department
VETERANS AFFAIRS, DEPARTMENT OF
Department code
Subagency
VETERANS AFFAIRS, DEPARTMENT OF
Subagency code
Office
242-NETWORK CONTRACT OFFICE 02 (36C242)
Organization path
Organization path codes
Office address
ALBANY, NY, 12208, USA
Place of performance
City code
State
State code
Postal code
Country

Points of contact

Contact details from the current notice version.

Notice description

Source text reproduced without an AI summary.

This is a notice of intent to award a sole source contract and is not a request for quotes. The Department of Veterans Affairs on behalf of the Buffalo VA Medical Center intends to award a Firm Fixed Price (FFP), sole source action to Large Businesses (LB). Name of Contractor: Thermo Fisher Scientific Street Address: 5781 Van Allen Way City, State, Zip: Carlsbad, CA 92008 USA The Pathology and Laboratory Medicine Department requires reagents and supplies outlined in this procurement to continue to perform patient testing on the Thermo Fisher Genexus instrument, and Genexus Purification System. Both instruments are owned and operated by the Buffalo VAMC Pathology and Laboratory Medicine department. The Genexus instrument utilizes the Oncomine Precision Assay which enables simultaneous detection of biomarkers across 50 genes, including key targets within EGFR, BRAF, KRAS, ALK, ROS1, NTRK, RET, HER2, and others, from solid tissue samples. Genomic profiling of tumors from cancer patients facilitates molecular-guided therapy. The OPA NGS panel has significant clinical utility in cancer treatment by providing comprehensive genomic profiling of a tumor sample, allowing healthcare providers to identify actionable genetic alterations and select the most appropriate targeted therapies for a patient based on their specific tumor mutations, leading to more effective treatment plans. Item number Description Quantity A40261 Ion Torrent Genexus Barcodes 1-32- AS HD 12 A40266 Ion Torrent Genexus Pipette tips 7 4483354 96-well plates (20/box) 4 A40269 Ion Torrent GX5 Chip and Genexus Coupler 6 A40271 Genexus Sequencing Kit 6 AB0626 Adhesive Foil Seals Microp Lates oe PCR Plates 1 A40263 Genexus Templating Strips 3 and 4-GX5 (8/BOX) 7 A45539 Genexus� FFPE DNA/RNA Purification Kit 6 A46291 Oncomine Precision Assay GX 12 This notice is being published in accordance with Federal Acquisition Regulation (FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. This is a notice of intent to award a sole source contract and is not a request for competitive quotes/proposals. The statutory authority for this sole source procurement is prescribed by FAR 13.105(a). The Department of Veterans Affairs, Buffalo, NY location intends to issue a sole source award contract to Thermo Fisher Scientific, all responsible sources may submit a capability statement demonstrating the ability to provide the requested services, which shall be considered by the agency before the intended award date. The Government shall not reimburse interested sources for any information provided. No requests for capability briefings will be honored. NAICS Code: 325413 In-Vitro Diagnostic Substance Manufacturing Veterans Health Administration prohibits the use of gray market items in their Medical Centers. Gray market items are considered to be items outside of the original equipment manufacturer s intended distribution channels. This notice is not a request for quotes; however, all responsible sources may submit a capability statement which shall be considered by the Government. All capability statements must be received by no later than 10:00 AM Eastern Standard Time on August 27, 2025. Responses to be submitted to Morgan Weeks, Contracting Officer at Morgan.Weeks1@va.gov. A determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Gove

Comparable award range

Historical award values for work matched by the fixed rubric—not an estimate of this opportunity.

No past awards scored highly enough to form a comparable range.

Comparable awards

The match score is decomposed so each comparison can be challenged.

No comparable awards are attached to this notice.

Amendment history

A version is preserved whenever the normalized notice contents change.

VersionNotice typeObservedResponses dueContent hash
1Special NoticeAug 22, 2026Aug 27, 2026, 2:00 PM UTC06f4a44e2ed9cc6e
2Special NoticeAug 28, 2026Aug 27, 2026, 2:00 PM UTC45fa1d0d24c34377

Record provenance

Field-level lineage for the current opportunity version.

FieldSourceSource as ofParserTransform
agency_nameSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
archive_dateSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
archive_typeSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
base_typeSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
contactsSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
descriptionSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
naics_codeSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
notice_idSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
notice_typeSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_citySAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_country_codeSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_nameSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_postal_codeSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_state_codeSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
organization_typeSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
posted_dateSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
psc_codeSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
response_deadlineSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
sam_urlSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
solicitation_numberSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
subagency_nameSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
titleSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3
upstream_activeSAM.gov Contract OpportunitiesAug 22, 2026sam_opportunity_snapshot@2026.08.22026.08.3

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

  1. 1Notice fields come from the SAM.gov contract opportunities record last seen Aug 29, 2026. SAM.gov remains authoritative.

Note 1 covers the solicitation record. No synthetic FAQ or inferred solicitation value is published.

6550--INTENT TO SOLE SOURCE - Buffalo VA Thermo Fisher GENEXUS Reagents — federal contract opportunity · BidBenchmark